Pre-doctoral Training

Georgetown University
An interdisciplinary graduate training program that is closely integrated with the training programs in Neurosciences and Pharmacology. Multidisciplinary research opportunities utilize a variety of techniques from the molecular level to integrated systems and behavioral neuroscience. Faculty research focuses on the study of the effects of abused substances on cognition, receptors and signal transduction pathways, neuroimmune responses and development.
Project Director: Barbara M. Bayer, Ph.D.
bayerb@georgetown.edu

University of California, Irvine
This program is designed to train pre-doctoral students in the fundamentals of pharmacology and neuroscience with a special emphasis on substance abuse research. The goal of the program is to expose trainees to substance abuse research and prepare them for independent research careers in neuroscience and pharmacology in basic science departments, medical schools, and non-academic research laboratories. The program combines training in molecular and cellular pharmacology with training in chemical neuroanatomy and behavioral neurosciences. The 20 primary faculty have appointments across five different departments. All mentors are experienced trainers with active research laboratories. The program supports six predoctoral traineeships. Website at http://www.ucihs.uci.edu/pharmaco/TrainingGrant/
Project Director: Daniele Piomelli, Ph.D.
piomelli@uci.edu

University of Michigan
Interdisciplinary training program with research opportunities ranging from the level of
molecular biology, to integrative and systems neuroscience to behavioral pharmacology.
Faculty study a wide range of abused substances and neural systems related to their actions, including opioids, psychomotor stimulants, PCP, nicotine and sedative-hypnotics.
Project Director: Terry Robinson, Ph.D.
ter@umich.edu

University of North Carolina
Graduate training in areas related to drug and alcohol abuse. Areas include: behavioral
pharmacology, neurobiology, neuropharmacology, neuroimmunology, genetic/behavioral correlates of drug dependence and clinical psychology.
Project Director: Linda Dykstra, Ph.D.
ldykstra@unc.edu

Post-doctoral Training

Arizona State University
Training consists of course work and directed research experiences in the areas of general ethnographic theory and methods, qualitative approaches to studying HIV risk behaviors, violence and drug abuse, research ethics, new intervention and prevention modalities, and computer-based qualitative data analysis processes.
Project Director: Joan Koss, Ph.D.
idjdk@imap1.asu.edu

Brookhaven National Laboratory
Post-doctoral training program in drug abuse research involving neuroimaging. The training environment includes positron emission tomography (PET and microPET) and magnetic resonance imaging (MRI and microMRI) groups with facilities for human, non-human primate and rodent studies. Areas of training include combined imaging/neuropsychological studies of drug abuse and addiction, and associated topics such as the development of radiotracers, imaging methodology, and image analysis techniques.
Project Director: Samuel John Gatley, Ph.D.
gatley@bnl.gov

Brown University, Center for Alcohol and Addiction Studies
Post-doctoral program training behavioral, pharmacologic, social and health care scientists for a career in substance abuse intervention outcome research. Fellows will be trained in conjunction with an existing NIAAA postdoctoral research program that has been in place since 1986. The Center's primary research focus is the discovery of more effective treatments and early interventions for alcohol and drug abuse.
Project Director: Damaris Rohsenow, Ph.D.
Coordinator: Peg Ciarlone
Postdoc_training@brown.edu

Columbia University
This is a post-doctoral training program focusing on the neural mechanisms underlying drug dependence. Studies will range from genetic analysis, synaptic plasticity, circuitry, second messenger systems, and characterization of the actions of receptors, transporters, and ion conductances, and explore the pathways of receptor and transporter regulation, neuritic pruning, modes of neuronal and glial cell death, and to establish pathways that may provide for regeneration. The ultimate goal of this program is to train the next generation of scientists to examine the effects of drug abuse.
Project Director: David Sulzer, Ph.D.
ds43@columbia.edu

Columbia University
Post-doctoral training program for physicians and psychologists interested in pursing research careers in substance abuse. The primary goal is to provide future research and academic psychiatrists and other clinicians with the research skills and clinical expertise to play substantive roles in advancing knowledge about the etiology and treatment of substance use disorders. Research fields include basic neuroscience, genetics, epidemiology, behavioral pharmacology, epidemiology, psychopharmacology, clinical trials and treatment research.
Project Director: Herbert Kleber, M.D.
hdk3@columbia.edu

Johns Hopkins University
Clinical research training program in human behavioral pharmacology. Candidates receive supervised clinical research training on various topics related to drug abuse, including intravenous drug abuse and the associated HIV risk behaviors involved in the spread of AIDS.
Project Director: George Bigelow, Ph.D.
bigelow@jhmi.edu

McLean Hospital, Harvard Medical School Alcohol and Drug Abuse Research Center
Multidisciplinary postdoctoral training in clinical, preclinical, basic and treatment-related research on drug abuse is provided by faculty at the Alcohol and Drug Abuse Research Center. Trainees may participate in studies of behavioral pharmacology, neuroendocrinology, neurobiology, evaluation of novel analgesics, and brain imaging (MRI, MRS, fMRS). This research program also offers training in medicinal chemistry to develop novel medications, and in clinical and preclinical evaluations of the safety and effectiveness of new medications for drug abuse treatment. This Center focuses on drug abuse problems in women and gender comparisons, including the interactions between abused substances and neuroendocrine hormones.
Project Director: Jack H. Mendelson, M.D.
jmendel@mclean.org

McLean Hospital, Harvard Medical School, NeuroImaging Center
Post-doctoral training in the field of brain imaging and drug abuse is offered as an integrated, multidisciplinary program jointly supported by the McLean Hospital/Harvard Medical School and Boston University School of Medicine. The primary goal is to provide trainees with skills in brain imaging technology (MRI, MRS, fMRI, EEG) and advanced psychopharmacology to be used in basic science and applied research projects that include: acute intoxicating effects of drugs, cue-induced craving, cognitive effects, withdrawal, sleep disturbances, medication compliance, treatment, medication development as well as translational research between animals and humans. Training includes both formal course work and laboratory rotations via one of four tracks: 1) MR Technology and Instrumentation Track; 2) Basic Clinical Research Track; 3) Clinical Treatment Track; and 4) Translational Research Track.
Project Director: Scott E. Lukas, Ph.D.
lukas@mclean.org

Send CV and statement of research interests to: Ronna J. Shostak, BPRL, McLean Hospital, 115 Mill St., Belmont, MA 02478, or email to shostak@mclean.harvard.edu.

Mount Sinai School of Medicine
Post-doctoral training in basic biomedical research on the pharmacology of drugs of abuse. Projects range from molecular biology to behavioral pharmacology: theoretical modeling of drug-receptor interactions, regulation of gene expression, molecular mechanisms of signal transduction, neurophysiology, neurotransmitter release, prenatal effects of drug abuse, opioid analgesia and opioid self-administration.
Project Director: Stuart C. Sealfon, Ph.D.
sealfs01@doc.mssm.edu

New York University School of Medicine
Post-doctoral training program emphasizing basic research. Faculty members have active research programs focusing on brain reward mechanisms, molecular biology of opioid receptors, signal transduction in tolerance and dependence, dopamine as an extrasynaptic neurotransmitter, structure, function, and regulation of monoamine transporters, preclinical development of medications against cocaine dependence, noradrenergic mechanisms of stress and psychostimulant effects, and CNS correlates of drug craving in humans.
Project Director: Eric Simon, Ph.D.
eric.simon@nyu.edu
Co-Director: Kenneth D. Carr, Ph.D.
kc16@nyu.edu

University of California, San Francisco
Postdoctoral program in drug abuse treatment and services research. Trainees work with a preceptor to design and implement studies on treatment of drug dependence, including nicotine dependence. Trainees also select a specific area of focus for independent research. Current research interests include trials of efficacy and effectiveness of psychosocial and pharmacologic treatment of drug abuse, including nicotine dependence; instrument development in drug abuse; diagnostic techniques and research on treatment tailored for HIV positive drug abusers and drug abusers with psychiatric and medical disorders; research on provision of services to drug abusing populations; innovative methodology including internet based studies; and treatment of complex patients in innovative settings.
Project Director: Sharon Hall, Ph.D.
smh@itsa.ucsf.edu

University of Michigan
This program offers post-doctoral training in the area of neurobiology and pharmacology of drugs of abuse, especially opioids and stimulants. The emphasis is on promoting scientific growth and acquiring conceptual and experimental tools key to understanding a) the basic biology of endogenous opioids and their receptors and the mechanisms of action of opiate drugs, b) the molecular, cellular, interneuronal and behavioral processes critical to drug seeking, drug dependence and drug tolerance. This endeavor is carried out in an interdisciplinary context, with research ranging from gene regulation to primate behavior.
Project Director: John Traynor, Ph.D.
jtraynor@umich.edu

Washington University
Multidisciplinary post-doctoral training program in drug abuse research with preceptors
from the Departments of Psychiatry, and the Division of Biostatistics and Infectious
Diseases. Research facilities include a renovated center for genetic and epidemiologic
studies with access to inpatients and outpatients of Barnes Jewish, Bliss and Childrens
Hospitals.
Project Director: Theodore J. Cicero, Ph.D.
cicerot@msnotes.wustl.edu

Yale University
The central theme of the research in this post-doctoral program is the development and evaluation of innovative harmacologic and behavioral treatments for substance abusers. Training can range in areas from molecular neurobiology and enetics to pharmacology and behavioral treatments, psychiatric epidemiology and health services research of drug abuse. This is a rich training environment, faculty with broad interests, many are world-renowned in their field.
Project Director: Ismene Petrakis, M.D.
ismene.petrakis@yale.edu

Pre- and Post-Doctoral Training

Albany Medical College
This training program in neuropharmacology and neuroscience provides a multifaceted approach to understanding mechanisms of abused drugs and to developing new agents for treating addiction through an integrated program of didactic work and in-depth research experiences.
Project Director: Stanley Glick, M.D., Ph.D.
glicks@mail.amc.edu

Brown University, The Miriam Hospital
This post-doctoral training program focuses on clinical research training in the areas of prevention, diagnosis, and treatment of HIV, Hepatitis B and C, and STDs among substance users. The goal is to train MDs and PhDs in prevention intervention research and interventions to improve treatment and access to therapy for HIV, Hepatitis, TB, and STDs among "hard to reach" populations.
Project Director: Timothy P. Flanigan, M.D.
Administrator: Jennifer Hyde
jhyde@lifespan.org

Cornell University Medical College
The Pharmacology-Neuroscience Drug Abuse Training Program will provide the opportunity for young investigators to participate in basic and clinical research in drug abuse. Training Faculty interests include the phenotypic consequences for pain states, opioid tolerance, reward, anxiety or gaseous anesthetic action of the mutation or deletion of opioid, glutamatergic, GABA or serotonergic receptors, the role soluble and transmembrane adenylyl cyclases in opioid signal transduction, in vivo receptor and drug imaging techniques, anatomical and ultrastructure characterization of the dopaminergic, glutamatergic and opioid peptides systems as they relate to the effects of drugs of abuse, the biological basis of opioid, cocaine and alcohol tolerance and dependency, maternal-fetal pharmacodynamics of drugs of abuse, drug abuse prevention research and the clinical pharmacokinetics and pharmacodynamics of opioid and nonopioid analgesics. Predoctoral trainees will have a choice of a major concentration in either Pharmacology or Neuroscience. In addition to lectures and seminars devoted to topics in drug abuse, both the 5 pre and the 5 postdoctoral trainees will attend a biweekly Pain Conference at MSKCC where patient presentations are followed by a discussion with a multidisciplinary Pain Research Team of pain management, drug abuse and related issues. The program provides training in study design, biostatistics and the ethics of scientific research.
Project Director: Charles Inturrisi, Ph.D.
ceintur@med.cornell.edu

Emory University
This training program in The Neurobiology of Drug Abuse focuses on the mechanisms of drug use/abuse /dependence and offers interdisciplinary training. The goal is to produce scientists who have a depth of expertise in their main interest and a breadth of expertise in the neurobiology of drug abuse. The 18 faculty offer research in brain imaging, behavioral models, neuroanatomy, drug receptors and signal transduction, medications development and molecular biology and genetics.
Project Director: Michael J Kuhar, PhD.
mkuhar@rmy.emory.edu

Johns Hopkins Bloomberg School of Public Health
The primary goal of this new training program is to increase the number and quality of quantitatively adept scientists who, after training, will conduct population field studies and other epidemiologic research on drug dependence and on related hazards associated with illicit drug use.
Project Director: Howard D. Chilcoat, Sc.D.
hchilcoa@jhsph.edu

Louisiana State University Health Sciences Center
This training program focuses on the influence of stress and the subsequent activation of the HPA axis in addiction, with a special emphasis on the acquisition of and relapse to psychomotor stimulant use. This program is designed to provide trainees with a broad understanding of the pharmacology and neurobiology of drug abuse and how stress can impact these processes.
Project Director: Nicholas E. Goeders, Ph.D.
ngoede@lsuhsc.edu

Medical College of Virginia
The principal objective of this training program is to prepare pre-doctoral and post-doctoral students for academic careers as independent scientists in the area of drug abuse research. Pre-doctoral students may enter the drug abuse training program after completing at least one year in the graduate program of the department. They will have had courses in biochemistry, physiology and general pharmacology and will have been exposed to research in at least four different laboratories by the time that they enter the drug abuse training program.
Project Director: William Dewey, Ph.D.
wdewey@hsc.vcu.edu

Medical and Health Research Association of New York City, Inc. (MHRA)
This training program is designed to prepare social scientists for careers in research on drug abuse and HIV/AIDS. Training activities at National Development and Research Institutes (NDRI) emphasize: advanced courses in drug abuse theory and research methods and in substantive issues related to AIDS, crime, and other drug related topics. Fellows attend appropriate doctoral level courses at Columbia University, School of Public Health or other New York area universities.
Project Director: Bruce Johnson, Ph.D.
johnsonb@ndri.org

Medical University of South Carolina
Pre-doctoral and post-doctoral training for individuals who are interested in a multidisciplinary basic science and/or clinical approach to drug abuse issues. Our expertise is in translating research on the mechanisms of drug seeking behavior and its molecular/cellular substrates into pharmacotherapies for drug addiction. This site is the home of the South Carolina Node of the NIDA Clinical Trials Network.
Project Director: Jacqueline F. McGinty, Ph.D.
mcginty@musc.edu

Oregon Health Sciences University
This program will train specialists to conduct preclinical research ranging from the molecular to the behavioral level on the biological mechanisms underlying the development, maintenance, and elimination of drug-seeking behavior. Thirty-one faculty will serve as preceptors for trainees at the cellular/molecular level, using molecular biological, electrophysiological, and fluorescence and electron microscopic techniques; at the level of physiological, biochemical, and pharmacological systems, using receptor binding, autoradiography, in vivo microdialysis and voltammetry, in vitro perfusion, and electrophysiological techniques; and in pharmacogenetics/behavioral pharmacology, using behavioral testing, intravenous drug self-administration, quantitative genetics, and genetic mapping techniques.
Project Director: Kim Neve, Ph.D.
nevek@ohsu.edu

Temple University School of Medicine
This program provides inter-disciplinary training in several areas of drug abuse research including behavioral, cellular, and molecular pharmacology, neuroscience, and immunology. Our current research emphasis is on investigating the effects of opioids, cocaine, and cannabinoids on behavior and on the brain and immune system. Training of predoctoral and postdoctoral fellows from the Departments of Pharmacology, Microbiology and Immunology, Psychology, and Biochemistry is provided, with experienced senior drug abuse researchers in each department to serve as mentors. This program provides the trainees with the opportunity to learn a variety of research skills and helps prepare them for independent careers in academia, industry, or government. Detailed research program descriptions can be found on our web sites, www.temple.edu/csar and www.temple.edu/pharmacology.
Project Director: Ellen Unterwald, Ph.D.
Ellen.Unterwald@temple.edu

University of California, Los Angeles
The Drug Abuse Research Training Center in the UCLA Integrated Substance Abuse Program (ISAP) (http://www.uclaisap.org/) provides multidisciplinary as well as interdisciplinary training in the major areas of substance abuse research including pharmacology and medications development, neuroscience and brain imaging, clinical trials and behavioral treatments, health services, epidemiology, social, health, and criminal consequences of substance abuse, special populations, and the cognitive-behavioral process of addiction and addiction cessation. The Center trains pre-doctoral and post-doctoral fellows from psychiatry, psychology, sociology, public health, chemistry, biology, and nursing, offering them opportunity of working closely with more than 20 senior ISAP investigators representing all major areas in substance abuse research.
Project Director: Thomas Freese, Ph.D.
tefreese@ix.netcom.com

University of California, San Diego
The purpose of this program is to provide pre-and post-doctoral fellows training in basic neuroscience that is relevant to the understanding of how drugs of abuse modify brain function. This program spans areas such as chemistry for design and synthesis of opioid receptor ligands, biochemistry and macromolecular structure of protein components involved in neurotransmission, pharmacology, neurophysiology, neuroimmune and viral influences, neural systems in pain and behavior related to actions of drugs of abuse
Project Director: Vivian Y. Hook, Ph.D.
vhook@ucsd.edu

University of Chicago
This training program emphasizes an interdisciplinary approach aimed at characterizing the multiple actions of different drugs of abuse and deciphering the behavioral and neurobiological factors that contribute to their abuse. The programs span the neuropsychopharmacology, biochemistry, electrophysiology and molecular biology of drug abuse through to the study of behavioral and subjective effects of drugs in humans.
Project Director: Paul Vezina, Ph.D.
pvezina@yoda.bsd.uchicago.edu

University of Connecticut
This program seeks to develop scientists with a strong background in the discovery and synthesis of novel medications for drug abuse treatment. Rational drug design is combined with high throughput and combinatorial approaches currently utilized in the pharmaceutical industry.
Project Director: Alexandros Makriyannis, Ph.D.
makriyan@uconnvm.uconn.edu

University of lllinois - Chicago
Pre- and Post-doctoral training focuses on the etiology and prevention of adolescent substance abuse, violence, unsafe sexual behaviors and AIDS. We emphasize longitudinal etiology research and randomized trials of prevention programs. The program is located in the Health Research and Policy Centers, a cluster of 5 interdisciplinary research centers administered by the School of Public Health. This program allows fellows to work closely with faculty from various disciplines on ongoing etiology and prevention research projects and develop their own research programs.
Project Director: Brian Flay, D.Phil.
bflay@uic.edu

University of Kentucky
This is an interdisciplinary program involving 15 faculty from a variety of departments including Anatomy and Neurobiology, Pharmacy, Neurology, Molecular and Cellular Biochemistry, and Psychology whose objective is to prepare predoctoral and postdoctoral trainees for a career in drug abuse research. There is a rich tradition of drug abuse research at the University of Kentucky that currently includes a Center on Drug and Alcohol Research and a Center for Drug Abuse Research Translation. This program provided broad-based training in modern concepts of drug abuse research with an emphasis on studies of receptors involved in drugs of abuse, the development of ligands which interact with these receptors, enzymes that regulate opioid peptide action, and neuroAIDS. The focus of the training program is on the use of a spectrum of state-of-the-art methodological approaches such as structural biology, proteomics, molecular modeling, and microarray technology in conjunction with molecular biology, pharmacology and basic neuroscience to explore the mechanisms that are the foundation of drug abuse research.
Project Director: Louis B. Hersh, Ph.D.
lhersh@uky.edu

University of Kentucky
This program focuses on biobehavioral research at the Center on Drug and Alcohol Research, the Center for Prevention Research, and the Residential Research Facility. Program prepares trainees to assume research responsibilities in academic, and other scientific organizations concerned with drug abuse and the behavioral aspects of health and medical care.
Project Director: Thomas Garrity, Ph.D.
tgarrit@pop.uky.edu

University of Miami
Pre- and post-doctoral training in adolescent drug abuse treatment. This training program focuses on the development of research competencies related to collaborative studies on a range of psychosocial therapies for adolescent drug abuse.
Project Director: Howard Liddle, Ed.D.
hliddle@med.miami.edu

University of Michigan
This interdisciplinary training program focuses on the intersection of behavioral, epidemiological, and neuroscientific perspectives in the study of substance abuse. Trainees are expected to write for and present to multidisciplinary audiences as well as develop research competencies in their respective disciplines. Trainees will work with two faculty mentors, one mentor from the trainee's discipline and the other mentor from a complementary discipline.
Project Director: Carol Boyd, Ph.D.
caroboyd@umich.edu

University of Minnesota
The purpose of this training program directed by Dr. Seybold, is to provide an institutional pre- and post-doctoral training program that combines a broadly based curriculum training in neuroscience with research training focused on neuroscience-oriented approaches to drug abuse. The curriculum is based on the graduate program in neuroscience, emphasizing cellular and molecular, systems, developmental, and behavioral components of neuroscience
Project Director: Virginia Seybold, Ph.D.
ginger@med.umn.edu

University of Minnesota
This is an interdisciplinary training program in the biology of drug abuse. Research training is available in laboratories offering a variety of experiences, e.g. receptor studies, signal transduction, transmitter neuropharmacology, animal and human behavioral pharmacology all approached from either a mechanistic or intervention strategy.
Project Director: Thomas Molitor, Ph.D.
molit001@tc.umn.edu

University of Pennsylvania
This program provides clinical and research training for physicians and post-doctoral researchers who wish to become qualified in treatment research for IV substance abusing patients, particularly as it relates to the care of those infected with, or at high risk, for infection with HIV. Trainees will be fully trained in all of the current behavioral psychological and pharmacological techniques.
Project Director: Charles O'Brien, M.D.
obrien@mail.trc.upenn.edu

University of Rochester
This program takes an interdisciplinary approach to the broad spectrum of the problems of drug abuse and the many directions of drug abuse research. The four divisions of the training program include: Behavioral Pharmacology, Biochemical Pharmacology, Clinical Pharmacology, and Molecular Pharmacology. Pre-doctoral students will be able to receive a Ph.D. degree from several interdisciplinary programs, including pharmacology, toxicology, psychology, and neuroscience.
Project Director: Jean Bidlack, Ph.D.
jean_bidlack@urmc.rochester.edu

University of South Florida
The objective of this program is to prepare individuals for AIDS research in terms of psychoneuroimmunology, drugs of abuse immunology and infectious diseases. The program provides training to investigate the mechanisms by which immunodeficiency viruses, including HIV as well as related viruses, cause disease and the involvement of drugs of abuse, especially marijuana, cocaine and opiates, in modulating such diseases.
Project Director: Herman Friedman, Ph.D.
hfriedma@coml.med.usf.edu

University of Texas Medical Branch at Galveston
This program provides training in the neural and pharmacological mechanisms of abused drugs. The training faculty consists of members from the Departments of Pharmacology and Toxicology, Anatomy and Neuroscience, Physiology and Biophysics and the Department of Human Biological Chemistry and Genetics. The faculty has expertise in molecular, biochemical, cellular, neural systems and behavioral aspects of drugs of abuse.
Project Director: Kathryn Cunningham, Ph.D.
cunningham@utmb.edu

The University of Texas Southwestern Medical Center at Dallas
Our program offers research training in diverse areas of neuroscience directly relevant to drug abuse and addiction. A distinguishing feature of the program is its multidisciplinary orientation. There is ongoing research at the level of molecular biology, genetics, cellular physiology, neuroanatomy, neuropharmacology, and behavioral neuroscience, and most trainees carry out research that spans several of these various disciplines. Trainees also benefit from the outstanding biomedical research community at UT Southwestern.
Project Director: Eric J. Nestler, M.D., Ph.D.
Eric.Nestler@UTSouthwestern.edu

University of Vermont
This training program is primarily involved in the behavioral pharmacology of human drug dependence. Research opportunities range from laboratory studies of human drug discrimination and self administration to clinical outpatient studies of behavioral and pharmacological treatment of IV cocaine abuse.
Project Director: Warren Bickel, Ph.D.
warren.bickel@uvm.edu

University of Washington
The unique strength of this faculty group is their expertise in the molecular pharmacology of signal transduction mechanisms likely to be affected by drugs of abuse. Previous research by this group includes 1) studies of the effects of opioids, phencyclidine, and cannabinoids on ion channel function, 2) the structure and biochemical properties of channels and enzymes known to be regulated by drugs of abuse, and 3) the effects of chronic exposure of opiates on the properties of specific neurons in the mammalian brain.
Project Director: Charles Chavkin, Ph.D.
cchavkin@u.washington.edu

University of Washington
This Nursing Research Training Program in Substance Abuse is interdisciplinary and offers two post-doctoral research fellowships for individuals holding a doctorate in Nursing; and two fellowships for individuals holding a doctorate in Psychology, Social Work, Psychiatry and/or other heath care disciplines. Additionally, there are two pre-doctoral traineeships for students enrolled in the University of Washington School of Nursing doctoral program. The training foci of this program are substance abuse epidemiological research and treatment research. The training opportunities, particularly in treatment research, are excellent. A NIDA Clinical Trials Network (CTN) is in progress at the University of Washington. There are ongoing clinical trials that combine psychosocial treatment with medication, intervention studies on substance abuse co-morbidities, and projects in the corrections/criminal justice/prison system. Numerous other training opportunities with other federally-funded mentor projects are also available.
Project Director: Elaine Adams Thompson Ph.D., RN
elainet@u.washington.edu

Wake Forest University School of Medicine
The purpose of this program is to provide research training that involves a multidisciplinary approach to examine the effects of drugs of abuse at several different levels of brain function. The program is organized around three principal areas of research: Molecular/Cellular Neurobiology, Neurobiological Systems, and Behavioral Neurobiology. Pre-doctoral students will have a choice of three different Ph.D. degree programs: Pharmacology, Physiology, and Neuroscience.
Project Director: Steven Childers, Ph.D.
childers@wfubmc.edu

Washington University, George Warren Brown School of Social Work
The Social Work Training in Addictions Research (STAR) pre-doctoral and post-doctoral training program focuses on research on services and treatment of substance abusing and comorbid populations. It is associated with the NIDA-funded Comorbidity and Addictions Center, whose primary objective is to advance research on multisector services for drug, alcohol, and comorbid problems to underserved populations. The program prepares trainees for academic research placements in tenure track or post-doctoral fellowship positions.
Project Director: Arlene Rubin Stiffman, Ph.D.
arstiff@gwbmail.wustl.edu

Washington University School of Medicine
This program offers a broad range of research opportunities for individuals wishing to give primary emphasis in their research to drug abuse epidemiology, comorbidity, prevention, assessment or biostatistics. This program seeks to recruit and equip researchers from other backgrounds such as social work, infectious disease and public health, with the special skills that are needed to address challenging problems that are specific to drug abuse research.
Project Director: Linda Cottler, Ph.D.
cottler@epi.wustl.edu

Wayne State University, Michigan
The purpose of this program is to provide pre-and post-doctoral fellows training in Cellular and Clinical Neurobiology. This program provides a comprehensive program of instruction in neurobiology, emphasizing the development of research capabilities in pharmacology, molecular/cellular biology, and clinical and behavioral aspects of substance abuse.
Project Director: Donald M. Kuhn, Ph.D.
dkuhn@med.wayne.edu

The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Thursday, October 14, 2004.